Caroline E. Van Der Minne
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFNα.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2024
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: October 17, 2023
Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study.
Journal: Journal for immunotherapy of cancer
Published: February 17, 2020
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: June 21, 2016
Neoantigen landscape dynamics during human melanoma-T cell interactions.
Journal: Nature
Published: February 18, 2016
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.
Journal: Cancer immunology, immunotherapy : CII
Published: July 16, 2013
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.
Journal: Cancer immunology, immunotherapy : CII
Published: February 13, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026